Combined therapy with inhaled nitric oxide and intravenous epoprostenol (prostacyclin) for critical pulmonary perfusion after the Fontan procedure.
Miyaji
Kagami
K
Department of Cardiovascular Surgery, Kanagawa Children's Medical Center, Yokohama, Japan. kagami111@aol.com
Nagata
Nobuhiro
N
Miyamoto
Takashi
T
Kitahori
Kazuo
K
D000280:Administration, Inhalation; D001784:Blood Gas Analysis; D002496:Central Venous Pressure / Q000187:drug effects; D002675:Child, Preschool; D004310:Double Outlet Right Ventricle / Q000150:complications / Q000601:surgery; D004359:Drug Therapy, Combination; D011464:Epoprostenol / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D018729:Fontan Procedure / Q000009:adverse effects* / Q000379:methods; D006352:Heart Ventricles / Q000002:abnormalities / Q000601:surgery; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D007262:Infusions, Intravenous; D008297:Male; D009569:Nitric Oxide / Q000494:pharmacology / Q000627:therapeutic use*; D011182:Postoperative Care / Q000379:methods*; D018633:Pulmonary Atresia / Q000150:complications / Q000601:surgery; D011652:Pulmonary Circulation / Q000187:drug effects; D011666:Pulmonary Valve Stenosis / Q000150:complications / Q000601:surgery; D013997:Time Factors; D016896:Treatment Outcome; D014655:Vascular Resistance / Q000187:drug effects
D009569:Nitric Oxide; D011464:Epoprostenol